
Investing.com – Belgium stocks were lower after the close on Wednesday, as losses in the Healthcare, Consumer Goods and Consumer Services sectors led shares lower.
At the close in Brussels, the BEL 20 lost 0.32%.
The best performers of the session on the BEL 20 were Solvay SA (EBR:SOLB), which rose 2.99% or 0.98 points to trade at 33.73 at the close. Meanwhile, Ackermans&Van Haaren NV (EBR:ACKB) added 2.17% or 4.00 points to end at 188.00 and Umicore SA (EBR:UMI) was up 1.38% or 0.15 points to 11.00 in late trade.
The worst performers of the session were Galapagos NV (AS:GLPG), which fell 1.30% or 0.36 points to trade at 27.34 at the close. Argen-X (EBR:ARGX) declined 1.29% or 6.20 points to end at 475.70 and Anheuser Busch Inbev SA NV (EBR:ABI) was down 1.17% or 0.68 points to 57.32.
Falling stocks outnumbered advancing ones on the Brussels Stock Exchange by 53 to 45 and 8 ended unchanged.
Shares in Ackermans&Van Haaren NV (EBR:ACKB) rose to all time highs; rising 2.17% or 4.00 to 188.00.
Gold Futures for December delivery was up 0.15% or 3.90 to $2,596.30 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in November fell 0.74% or 0.52 to hit $69.44 a barrel, while the November Brent oil contract fell 0.76% or 0.56 to trade at $73.14 a barrel.
EUR/USD was unchanged 0.03% to 1.11, while EUR/GBP unchanged 0.26% to 0.84.
The US Dollar Index Futures was up 0.04% at 100.61.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.